Wexford Capital’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$574K | – | 175 |
|
|
2019
Q4 | $574K | Sell |
10,000
-10,000
| -50% | -$574K | 0.09% | 101 |
|
|
2019
Q3 | $719K | Sell |
20,000
-10,000
| -33% | -$360K | 0.1% | 86 |
|
|
2019
Q2 | $932K | Sell |
30,000
-10,000
| -25% | -$311K | 0.11% | 88 |
|
|
2019
Q1 | $938K | Hold |
40,000
| – | – | 0.08% | 71 |
|
|
2018
Q4 | $550K | Buy |
40,000
+20,000
| +100% | +$275K | 0.05% | 66 |
|
|
2018
Q3 | $200K | Buy |
+20,000
| New | +$200K | 0.01% | 135 |
|